BDSI Insider Trading Activity and SEC Form 4 Filings
BDSI insider trading summary
No open-market insider purchases or sales of Biodelivery Sciences International Inc (BDSI) have been reported on SEC Form 4 in the past 12 months.
Latest BDSI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 4, 2022 | James Vollins | See Remarks | Sell | $67K (18,541 @ $3.60) |
| Dec 2, 2021 | Mark A Sirgo | Director | Buy | $50K (18,587 @ $2.69) |
| Nov 19, 2021 | Broadfin Capital, LLC | Director | Buy | $306K (100,000 @ $3.06) |
| Nov 19, 2021 | Broadfin Healthcare Master Fund Ltd | Director | Buy | $306K (100,000 @ $3.06) |
| Nov 19, 2021 | Kevin Kotler | Director | Buy | $306K (100,000 @ $3.06) |
| Nov 18, 2021 | Mark A Sirgo | Director | Sell | $30K (10,000 @ $3.04) |
| Nov 12, 2021 | Broadfin Capital, LLC | Director | Buy | $320K (100,000 @ $3.20) |
| Nov 12, 2021 | Kevin Kotler | Director | Buy | $320K (100,000 @ $3.20) |
| Nov 12, 2021 | Broadfin Healthcare Master Fund Ltd | Director | Buy | $320K (100,000 @ $3.20) |
| Nov 11, 2021 | Mark A Sirgo | Director | Buy | $51K (16,000 @ $3.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.